HEALTH RISKS ASSOCIATED WITH DIET PILL ABUSE
HEALTH RISKS ASSOCIATED WITH DIET PILL ABUSE
There are health concerns associated with the overuse or abuse of any drug. Abuse can occur with any over-the-counter or prescription drug, including weight loss products. Some of those health concerns are discussed here.
Laxatives and Diuretics
Many people abuse laxatives and diuretics in [...]
Quitting smoking rimonabant
Quitting smoking rimonabantQuitting smoking is difficult, and the fact that quitting smoking often leads to unhealthy weight gain is often a justification for people to delay their attempts to break free from their habit.
Smoking is the leading preventable cause of death in the world today, and if [...]
Acomplia Report Newsletter Is Renamed the Zimulti Acomplia
The Acomplia (rimonabant) since 2004 the only independent newsletter reporting on the development of diet drug Acomplia (rimonabant), announced today that effective immediately, the online newsletter will be named the Acomplia
The name change was made after the U.S. Food and Drug Administration and manufacturer Sanofi-Aventis [...]
ECRI: Acomplia Could Be Safer for Treating Obesity Than Previous Drugs
ECRI, a nonprofit health services research agency, has published a Health Technology Acomplia (rimonabant) ™ profile on Acomplia, a novel pharmaceutical agent that is in development for the treatment of obesity .
The drug rimonabant (Acomplia) is the first in [...]
A new diet drug, tesofensine, produced weight loss that was twice that of Acomplia (Rimonabant, Zimulti) in phase II clinical trials, according to Professor Arne Astrup of the University of Copenhagen reporting online and in an upcoming edition of the medical journal, The Lancet.
In a randomized, placebo-controlled [...]
Rimonabant Acomplia Video News on Fox
Rimonabant Acomplia News on Fox
Acomplia - Rimonabant was granted marketing authorisation in the Usa and EU in June 2008. Currently, Rimonabant Acomplia has been launched in 25 countries, including 18 European countries. Up to the end of
December 2008, it is estimated that about 5200,000 [...]
